Mesirow Financial Investment Management - Fixed Income’s AbbVie ABBV Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,284	Closed	-$947K	–	235
2016 Q2	$947K	Sell	15,284 -13,249	-46%	-$807K	0.06%	130
2016 Q1	$1.63M	Hold	28,533	–	–	0.75%	55
2015 Q4	$1.69M	Sell	28,533 -146	-0.5%	-$8.41K	0.78%	50
2015 Q3	$1.56M	Sell	28,679 -4,822	-14%	-$314K	0.44%	84
2015 Q2	$2.25M	Buy	33,501 +8	+0%	+$522	0.54%	73
2015 Q1	$1.96M	Buy	33,493 +7,787	+30%	+$470K	0.47%	81
2014 Q4	$1.68M	Sell	25,706 -13,377	-34%	-$843K	0.42%	93
2014 Q3	$2.26M	Buy	39,083 +23,099	+145%	+$1.28M	0.57%	66
2014 Q2	$902K	Buy	+15,984	New	+$839K	0.22%	128

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's ABBV Position: Q3 2016 in Review

Mesirow Financial Investment Management - Fixed Income sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 15,284 shares — an estimated $947K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in ABBV in Q2 2014 and held it in 9 quarters. The position peaked at $2.26M in Q3 2014. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

Mesirow Financial Investment Management - Fixed Income reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 15,284 AbbVie shares in Q3 2016, an estimated $947K.
Mesirow Financial Investment Management - Fixed Income first reported a position in AbbVie in Q2 2014 and held it in 9 quarters.
Mesirow Financial Investment Management - Fixed Income's AbbVie position peaked at $2.26M in Q3 2014.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2016, filed 28 Oct 2016.